Purple Biotech Ltd. (ADR) share price logo

Purple Biotech Ltd. (ADR)

NASDAQ: PPBT

Small Cap

$1.64

-0.05

(-2.96%)

as on

Purple Biotech Ltd. (ADR) Stock Performance

as on June 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.51
    $1.78
    downward going graph

    7.93%

    Downside

    8.54%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.42
    $29.00
    downward going graph

    13.41%

    Downside

    1668.29%

    Upside

    downward going graph

Purple Biotech Ltd. (ADR) share price movements today

Previous Close
$1.69
Open
$1.65
Volume
508.3K
Day's Low - High
$1.51 - $1.78
52 Week Low - High
$1.42 - $29.00

Purple Biotech Ltd. (ADR) Historical Returns

1 Month Return
-58.38 %
3 Month Return
-58.9 %
1 Year Return
-93.33 %
3 Year Return
-99.49 %
5 Year Return
-99.84 %

Purple Biotech Ltd. (ADR) Stock Fundamentals & Key Indicators

Check Purple Biotech Ltd. (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6M

EPS (TTM)

-5.31

Dividend Yield

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-3.629517543859649

PEG Ratio

0

Return On Equity TTM

-123.35%

Purple Biotech Ltd. (ADR) Stock Valuation

Track how Purple Biotech Ltd. (ADR) P/E has moved over time to understand its valuation trends.

Purple Biotech Ltd. (ADR) in the last 5 years

  • Overview

  • Trends

Lowest (-12.71x)

September 30, 2021

Industry (-3.63x)

June 17, 2026

Today (0.00x)

June 17, 2026

Highest (-0.56x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 0.00x

Purple Biotech Ltd. (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Purple Biotech Ltd. (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Purple Biotech Ltd. (ADR) image
Purple Biotech Ltd. (ADR)
NA$1.6M-99.84%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$38.4B63.66%72.4912.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.3B140.59%26.7335.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$64.5B14.69%15.0229.65%0.58%

Stock Returns calculator for Purple Biotech Ltd. (ADR) Stock including INR - Dollar returns

The Purple Biotech Ltd. (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Purple Biotech Ltd. (ADR) investment value today

Current value as on today

₹7,343

Returns

-₹92,657

(-92.66%)

Returns from Purple Biotech Ltd. (ADR) Stock

-₹93,333 (-93.33%)

Dollar Impact

₹676 (+0.68%)

Indian Investors' Interest in Purple Biotech Ltd. (ADR) Stock

Search interest for Purple Biotech Ltd. (ADR) Stock has increased by 183% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:183% versus previous 30 day period

Purple Biotech Ltd. (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
0
0
0
0
0
0
0
0
Operating Income
-6
-4
-3
-2
-1
-1
-1
-1
-2
-2
EBITDA
-4
-3
-2
0
0
-1
-1
-1
-2
-2
Interest Expense
2
0
0
0
0
0
-
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-3
-2
0
0
0
-1
-1
-23
0
Income Tax Expense
1
0
0
-
-
-
-
-
-
-
Net Income
-4
-3
-2
0
0
0
-1
-1
-23
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Purple Biotech Ltd. (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
1
1
0
0
0
-
-
Gross Profit
0
1
0
0
0
0
0
0
0
Operating Income
-11
-7
-7
-13
-17
-22
-22
-11
-27
EBITDA
-12
-5
-6
-28
-17
-21
-19
-7
-26
Interest Expense
0
0
0
0
0
0
2
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-5
-5
-28
-17
-21
-19
-7
-26
Income Tax Expense
0
0
0
-15
0
0
0
-
-
Net Income
-12
-5
-5
-27
-18
-21
0
-7
-26
Net Profit Margin
-12177.00%
-520.00%
-585.00%
-2799.90%
5745.00%
2381.10%
-10.15%
0.00%
0.00%

Purple Biotech Ltd. (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-3
-2
0
0
0
-1
-1
-23
0
Operating Cash Flow
-5
-3
-3
-2
-1
-1
-1
-1
-3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
2
3
0
0
5
0
0
Change in Cash
-4
-3
-1
1
-1
-1
4
0
-3

Purple Biotech Ltd. (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-5
-5
-28
-17
-21
-19
-7
-26
Operating Cash Flow
-8
-8
-5
-12
-15
-16
-19
-14
-5
Investing Cash Flow
2
2
0
-49
13
19
13
0
0
Financing Cash Flow
2
7
5
68
1
1
5
6
6
Change in Cash
-2
1
0
6
0
4
0
-7
1

Global Institutional Holdings in Purple Biotech Ltd. (ADR)

Funds
Holdings
JONES FINANCIAL COMPANIES LLLP
0%
Virtu Financial LLC
0.53%
Two Sigma Advisers, LLC
0.16%
Morgan Stanley - Brokerage Accounts
0.06%
Danske Bank A/S.
0%
See all

Purple Biotech Ltd. (ADR) News & Key Events

  • img

    Today's Timeline - 30 October

    Thu, 03:08 PM

    -

    PPBT shares dipped 19.1% in pre-market after an 82% jump due to achieving a commercially viable yield for IM1240.

    Thu, 09:03 PM

    -

    Purple Biotech's stock surged 81% after announcing a production milestone for IM1240, a tri-specific antibody targeting cancer.

Insights on Purple Biotech Ltd. (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Purple Biotech Ltd. American Depositary Shares has experienced a drawdown of -99.5%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 78.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 20.8% return, outperforming this stock by 114.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PPBT stock has moved down by -44.6%

About Purple Biotech Ltd. (ADR)

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and CAPTN-3 - IM1240 and IM1305, multi-valent antibody designed to activate anti-tumoral immune response against TAA positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel.
OrganisationPurple Biotech Ltd. (ADR)
Headquarters4 Oppenheimer Street, Rehovot, Israel, 7670104
IndustryBiotechnology
CEOMr. Gil Efron CPA, M.A.
E-voting on sharesClick here to vote

Key Management of Purple Biotech Ltd. (ADR)

Name

Title

Mr. Gil Efron CPA, M.A.

CEO & Director

Mr. Shai Lankry CPA, M.B.A.

Chief Financial Officer

Dr. Michael Schickler Ph.D.

Head of Clinical & Regulatory Affairs

FAQs

What is Purple Biotech Ltd. (ADR) share price today?

Purple Biotech Ltd. (ADR) share price today is $1.64 as on at the close of the market. Purple Biotech Ltd. (ADR) share today touched a day high of $1.78 and a low of $1.51.

What is the 52 week high and 52 week low for Purple Biotech Ltd. (ADR) share?

Purple Biotech Ltd. (ADR) share touched a 52 week high of $29 on and a 52 week low of $1.42 on . Purple Biotech Ltd. (ADR) stock price today i.e. is closed at $1.64,which is 94.34% down from its 52 week high and 15.49% up from its 52 week low.

What is Purple Biotech Ltd. (ADR)'s market capitalisation today?

Purple Biotech Ltd. (ADR) market capitalisation is $0.00T as on .

How to invest in Purple Biotech Ltd. (ADR) Stock (PPBT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Purple Biotech Ltd. (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Purple Biotech Ltd. (ADR) Shares that will get you 0.9146 shares as per Purple Biotech Ltd. (ADR) share price of $1.64 per share as on June 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy Purple Biotech Ltd. (ADR) Stock (PPBT) from India?

Indian investors can start investing in Purple Biotech Ltd. (ADR) (PPBT) shares with as little as ₹94.55 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in Purple Biotech Ltd. (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Purple Biotech Ltd. (ADR) share’s latest price of $1.64 as on June 17, 2026 at 8:45 am IST, you will get 6.0976 shares of Purple Biotech Ltd. (ADR). Learn more about fractional shares .

What are the returns that Purple Biotech Ltd. (ADR) has given to Indian investors in the last 5 years?

Purple Biotech Ltd. (ADR) stock has given -99.84% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?